BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Amarapurkar DN. Telbivudine: A new treatment for chronic hepatitis B. World J Gastroenterol 2007; 13(46): 6150-6155 [PMID: 18069753 DOI: 10.3748/wjg.v13.i46.6150]
URL: https://www.wjgnet.com/1007-9327/full/v13/i46/6150.htm
Number Citing Articles
J. Liu, T. Chen, Y. Zhao. Telbivudine therapy for gravidas with chronic hepatitis B infection and patients at risk of renal impairmentJournal of Viral Hepatitis 2017; 24: 6 doi: 10.1111/jvh.12787
Erik O. Soley, Zachary J. Devereaux, L.A. Hamlow, G. Berden, J. Oomens, M.T. Rodgers. IRMPD action spectroscopy, ER-CID experiments, and theoretical approaches investigate intrinsic L-thymidine properties compared to D-thymidine: Findings support robust methodologyInternational Journal of Mass Spectrometry 2019; 441: 32 doi: 10.1016/j.ijms.2019.04.003
Li-fen Han, Jian-ming Zheng, Li-qing Zheng, Hai-bing Gao, Li-xia Chen, Qing-ling Xu, Yi-hong Chai, Xin Zhang, Chen Pan, Lv-feng Yao. Telbivudine can safely reduce mother-to-child transmission in chronic hepatitis B women after 12 weeks of gestationBMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-4250-6
Jinxin Zheng, Minggui Deng, Xiaoliang Qiu, Zhong Chen, Duoyun Li, Xiangbin Deng, Qiwen Deng, Zhijian Yu. Rhabdomyolysis, lactic acidosis, and multiple organ failure during telbivudine treatment for hepatitis B: a case report and review of the literatureJournal of Medical Case Reports 2017; 11(1) doi: 10.1186/s13256-017-1498-6
Florina-Daniela Cojocaru, Doru Botezat, Ioannis Gardikiotis, Cristina-Mariana Uritu, Gianina Dodi, Laura Trandafir, Ciprian Rezus, Elena Rezus, Bogdan-Ionel Tamba, Cosmin-Teodor Mihai. Nanomaterials Designed for Antiviral Drug Delivery Transport across Biological BarriersPharmaceutics 2020; 12(2): 171 doi: 10.3390/pharmaceutics12020171
Yarden Ariav, James H Ch’ng, Heather R. Christofk, Noga Ron-Harel, Ayelet Erez. Targeting nucleotide metabolism as the nexus of viral infections, cancer, and the immune responseScience Advances 2021; 7(21): eabg6165 doi: 10.1126/sciadv.abg6165